In 2020-2021, I carried out my Biochemistry Part II project in the Draper Group. I produced, engineered, and characterised a panel of Ebola virus specific antibodies with the aim of improving their efficacy and potency for potential use as therapeutic and prophylactic agents.
Since graduating, I worked for two years under the supervision of Professor Bannard in the Weatherall Institute of Molecular Medicine (WIMM), where I sought to understand the core immunological principles of B cells and germinal center biology.
Recently, I have re-joined the Draper Group as a Research Assistant, and my current role involves working in the preclinical development of malaria vaccines and antibody therapeutics. Primarily, I am responsible for the production and characterisation of antibodies in the group.